WO2002096444A3 - Plumbago europaea constituents for use against psoriasis and hair loss - Google Patents

Plumbago europaea constituents for use against psoriasis and hair loss Download PDF

Info

Publication number
WO2002096444A3
WO2002096444A3 PCT/DE2002/001958 DE0201958W WO02096444A3 WO 2002096444 A3 WO2002096444 A3 WO 2002096444A3 DE 0201958 W DE0201958 W DE 0201958W WO 02096444 A3 WO02096444 A3 WO 02096444A3
Authority
WO
WIPO (PCT)
Prior art keywords
constituents
plumbago
europaea
composition
natural origin
Prior art date
Application number
PCT/DE2002/001958
Other languages
German (de)
French (fr)
Other versions
WO2002096444A2 (en
Inventor
Sofia Karassalidou-Mueller
Original Assignee
Sofia Karassalidou-Mueller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sofia Karassalidou-Mueller filed Critical Sofia Karassalidou-Mueller
Priority to AU2002317678A priority Critical patent/AU2002317678A1/en
Publication of WO2002096444A2 publication Critical patent/WO2002096444A2/en
Publication of WO2002096444A3 publication Critical patent/WO2002096444A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a composition having a therapeutic activity, to the use of the composition, and to a method for producing the same. The aim of the invention is to create a therapeutic agent, particularly for therapeutically treating psora (psoriasis) and hair loss, which does not result in any cytotoxic effect while exhibiting a good activity and, in addition, has essentially no miscellaneous side-effects. To this end, the inventive composition having a therapeutic activity is comprised of constituents extracted from the plant Plumbago europaea and of at least one additional constituent of natural origin. The constituents extracted from Plumbago europaea in conjunction with additional constituents of natural origin, e.g. dairy products or garlic extract, exhibit a distinct therapeutic effect when externally applied without any undesired side-effects with the exception of temporary skin irritations at the beginning of treatment. Absolutely no cytotoxic effects are observed due to the natural origin of the composition.
PCT/DE2002/001958 2001-05-28 2002-05-28 Plumbago europaea constituents for use against psoriasis and hair loss WO2002096444A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002317678A AU2002317678A1 (en) 2001-05-28 2002-05-28 Plumbago europaea constituents for use against psoriasis and hair loss

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10126023.7 2001-05-28
DE10126023A DE10126023A1 (en) 2001-05-28 2001-05-28 Composition with therapeutic efficacy

Publications (2)

Publication Number Publication Date
WO2002096444A2 WO2002096444A2 (en) 2002-12-05
WO2002096444A3 true WO2002096444A3 (en) 2003-12-04

Family

ID=7686453

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2002/001958 WO2002096444A2 (en) 2001-05-28 2002-05-28 Plumbago europaea constituents for use against psoriasis and hair loss

Country Status (3)

Country Link
AU (1) AU2002317678A1 (en)
DE (1) DE10126023A1 (en)
WO (1) WO2002096444A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007040025A1 (en) * 2007-08-24 2009-02-26 Muhamad Karwan Hair restorer, useful e.g. for external application on skin and as shampoo, conditioner, hair tonic and lotion, comprises component of aqueous extract of bulbous plant (Alliaceae) and/or bulbous plant oil

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080401A (en) * 1998-11-19 2000-06-27 Reddy; Malireddy S. Herbal and pharmaceutical drugs enhanced with probiotics

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
DATABASE MEDLINE [online] April 1997 (1997-04-01), KINI D P ET AL: "Antitumor and antifertility activities of plumbagin controlled release formulations.", XP002217228, Database accession no. NLM9315238 *
DATABASE MEDLINE [online] June 1977 (1977-06-01), PREMAKUMARI P ET AL: "Antifertility activity of plumbagin.", XP002217227, Database accession no. NLM12260179 *
GRIEVE M,LEYEL CF: "A MODERN HERBAL", 1981, MOUNTAIN ROSE HERBS, XP002217226 *
INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY. INDIA APR 1997, vol. 35, no. 4, April 1997 (1997-04-01), pages 374 - 379, ISSN: 0019-5189 *
NAHALKA J ET AL: "Production of plumbagin by cell suspension cultures of Drosophyllum lusitanicum Link", JOURNAL OF BIOTECHNOLOGY, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 49, no. 1, 20 August 1996 (1996-08-20), pages 153 - 161, XP004037103, ISSN: 0168-1656 *
THE INDIAN JOURNAL OF MEDICAL RESEARCH. UNITED STATES JUN 1977, vol. 65, no. 6, June 1977 (1977-06-01), pages 829 - 838, ISSN: 0971-5916 *

Also Published As

Publication number Publication date
WO2002096444A2 (en) 2002-12-05
DE10126023A1 (en) 2002-12-12
AU2002317678A1 (en) 2002-12-09

Similar Documents

Publication Publication Date Title
WO2001015678A3 (en) Topical use of kappa opioid agonists to treat otic pain
WO1998010767A3 (en) Use of quinazoline derivatives for the manufacture of a medicament in the treatment of hyperproliferative skin disorders
BRPI0006634B8 (en) topical composition comprising feverfew extract in the treatment and prevention of inflammatory disorders
PL370795A1 (en) Composition based on etyllinoleate and triethylcitrate for the treatment of seborrhea and acne
EP1303284A4 (en) Compositions and methods for the treatment of skin damage
WO2003068171A3 (en) Method and composition for treatment of inflammation and aids-associated neurological disorders
WO2001074314A3 (en) Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
BR0007404A (en) Soy compositions for depigmentation and skin care
TW200505490A (en) Cosmetic compositions and methods for using same to improve the aesthetic appearance of skin
CA2173457A1 (en) Use of 5-alpha reductase inhibitorsand compositions for treating androg enic alopecia
WO2006068778A3 (en) The use of plant extracts to prevent and/or reduce the signs of subjective discomfort and/or irritation in the topical application of cosmetic products
BR0212576A (en) Method for the treatment of skin disorders
WO2003092617A3 (en) Combinations for the treatment of inflammatory skin disorders
WO2002007669A3 (en) Phospholipid derivatives of valproic acid and mixtures thereof
WO2004060289A3 (en) Use of purslane to treat facial wrinkles
TW200513271A (en) Topical treatment of skin conditions
WO2004017924A3 (en) Methods of treating involuntary facial spasms and facial wrinkles
CA2275167A1 (en) The topical use of kappa opioid agonists to treat ocular pain
WO2003039453A3 (en) Novel benzoyl peroxide compositions for the treatment of dermatological disorders and methods for their use
WO2003013554A3 (en) Aromatase inhibitors from broussonetia papyrifera
WO2004103353A3 (en) Topical treatment of sebum related skin conditions
MXPA04001289A (en) Cosmetic composition and method of treating skin.
WO2001015677A3 (en) Use of 5-ht1b/1d agonists to treat otic pain
WO2003049667A3 (en) The method of treating cancer
WO2004105689A3 (en) Topical composition for the treatment of skin disorders and methods of using the same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP